Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 354824-19-4 | MDL No. : | MFCD09740382 |
Formula : | C7H10N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ITKBAOSPYUIRMP-UHFFFAOYSA-N |
M.W : | 138.17 | Pubchem ID : | 16793564 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 38.4 |
TPSA : | 48.14 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.14 cm/s |
Log Po/w (iLOGP) : | 1.47 |
Log Po/w (XLOGP3) : | 0.01 |
Log Po/w (WLOGP) : | 0.4 |
Log Po/w (MLOGP) : | 0.01 |
Log Po/w (SILICOS-IT) : | 0.93 |
Consensus Log Po/w : | 0.56 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.01 |
Solubility : | 13.3 mg/ml ; 0.0966 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.57 |
Solubility : | 37.0 mg/ml ; 0.268 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.17 |
Solubility : | 0.936 mg/ml ; 0.00678 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.49 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H312-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | Stage #1: With ammonium acetate; sodium cyanoborohydride In methanol for 48 h; Stage #2: With hydrogenchloride In water |
Example 11: Synthesis of 3-aminomethyl-2-methoxypyridine EPO <DP n="34"/>24 25[00102] A round bottom flask was charged with 0.44g (3.23mM) of 2-methoxy-3- pyridine carboxaldehyde (24), 1.24g (16.15mM) of ammonium acetate, and 0.61g (19.69mM) of sodium cyanoborohydride. The flask was then flushed with argon, and then 5OmL of dry MeOH was added by syringe. The reaction was stirred for 2 days, at which point the MeOH was evaporated off. 25mL of water was added, and the mixture was brought to pH 2 with cone. HCl. This was extracted twice with EtOAc to remove the alcohol side product. The mixture was brought to pH 10 using sodium hydroxide pellets, saturated with NaCl, and extracted twice with DCM and once with EtOAc. The combined organics were dried and evaporated to give 0.3 Ig (69percent) of 3-aminomethyl-2- methoxypyridine (25). |
69% | Stage #1: With ammonium acetate; sodium cyanoborohydride In methanol for 48 h; Stage #2: With hydrogenchloride; water In methanol Stage #3: With sodium hydroxide; water In methanol |
Example 11 Synthesis of 3-aminomethyl-2-methoxypyridine A round bottom flask was charged with 0.44 g (3.23 mM) of 2-methoxy-3-pyridine carboxaldehyde (24), 1.24 g (16.15 mM) of ammonium acetate, and 0.61 g (19.69 mM) of sodium cyanoborohydride. The flask was then flushed with argon, and then 50 mL of dry MeOH was added by syringe. The reaction was stirred for 2 days, at which point the MeOH was evaporated off. 25 mL of water was added, and the mixture was brought to pH 2 with conc. HCl. This was extracted twice with EtOAc to remove the alcohol side product. The mixture was brought to pH 10 using sodium hydroxide pellets, saturated with NaCl, and extracted twice with DCM and once with EtOAc. The combined organics were dried and evaporated to give 0.31 g (69percent) of 3-aminomethyl-2-methoxypyridine (25). |
69% | With ammonium acetate; sodium cyanoborohydride In methanol for 48 h; | A round bottom flask was charged with 0.44g (3.23mM) of 2-methoxy-3-pyridine carboxaldehyde (24), 1.24g (16.15mM) of ammonium acetate, and 0.61g (19.69mM) of sodium cyanoborohydride. The flask was then flushed with argon, and then 5OmL of dry MeOH was added by syringe. The reaction was stirred for 2 days, at which point the MeOH was evaporated off. 25mL of water was added, and the mixture was brought to pH 2 with cone. HCl. This was extracted twice with EtOAc to remove the alcohol side product. The mixture was brought to pH 10 using sodium hydroxide pellets, saturated with NaCl, and extracted twice with DCM and once with EtOAc. The combined organics were dried and evaporated to give 0.31g (69percent) of 3-aminomethyl-2-methoxypyπdine (25). |
[ 112197-16-7 ]
(2-Methoxypyridin-3-yl)methanol
Similarity: 0.85
[ 1802489-58-2 ]
(6-Bromo-2-methoxypyridin-3-yl)methanamine
Similarity: 0.84
[ 760207-87-2 ]
5-Bromo-2-methoxy-3-methylpyridine
Similarity: 0.78
[ 1802489-58-2 ]
(6-Bromo-2-methoxypyridin-3-yl)methanamine
Similarity: 0.84
[ 1260663-96-4 ]
2-Methoxy-5-methylpyridin-4-amine
Similarity: 0.75
[ 112197-16-7 ]
(2-Methoxypyridin-3-yl)methanol
Similarity: 0.85
[ 1802489-58-2 ]
(6-Bromo-2-methoxypyridin-3-yl)methanamine
Similarity: 0.84
[ 760207-87-2 ]
5-Bromo-2-methoxy-3-methylpyridine
Similarity: 0.78